Maharashtra FDA Raids Snapdeal.com for Selling Prescription Drugs Online

The raid was conducted based on a tip-off which alleged that prescription drugs like Ascoril cough syrup, Vigora tablets, and other medicines were sold online.

The Maharashtra Food & Drugs Administration (FDA) has cracked down on Snapdeal’s offices in Goregaon, north-west Mumbai, for selling prescription drugs online, a top official said on Friday.

Its sleuths raided Snapdeal’s offices after a specific tip-off was received that prescription drugs like Ascoril cough syrup, Vigora tablets, and other medicines were being sold online, FDA Commissioner Harshadeep Kamble said. The FDA has also ordered a search of Snapdeal.com’s offices and godowns in this connection.

A Cell-Based New Platform to Identify Drugs for Fighting Viral Diseases
A platform that was previously created for HIV is now used to monitor the biomolecular activity of viruses inside their host cells to combat the Dengue virus.

Besides, Kamble said, the FDA will investigate Flipkart.com and Amazon.com offices to ascertain whether they are also indulging in such activities and has sought details from them in this regard.

The action against Snapdeal.com was initiated under the Drugs & Cosmetics Act, 1940 Sec. 18 (C), read with Rule 65, stipulating that only a licensed retailer can sell drugs and that too on the basis of a doctor’s prescription. Rule 65 also prescribes the relevant procedures to be adopted by pharmacy stores while selling prescription drugs, especially Schedule H drugs under the Act. Snapdeal.com is accused of selling various drugs, including those requiring a doctor’s prescription, and violating norms.

"Such type of online sale of drugs is not allowed as per the Act. Such kind of self-medication may be harmful to the patients. Snapdeal.com like agencies cannot act like doctor or pharmacist. "Through such vigilant actions, the FDA is trying to control the menace of Internet-based sale of drugs which could be harmful to the patients," Kamble said in a statement.

Cardiovascular Effects of Two Drugs for Diabetic Patients Show Neutral Results
The trials on two DPP-4 inhibitors, saxagliptin and alogliptin, concluded that the results show no evidence of either cardiovascular benefit or harm.

The official said Snapdeal.com has been asked to provide details of the people involved, medical stores, companies, their respective documents including agreements, challans, invoices, payment details etc.

The FDA has directed Snapdeal.com to immediately withdraw offers for sale and exhibition of such drugs from its e-commerce sites and delist them, which the company has agreed to comply with.

Apples, Dietary Polyphenols in a Cup of Green Tea May Help Anti-Cancer Drugs
Researchers have found polyphenols in green tea and apples block a signalling molecule called VEGF, which in the body can trigger atherosclerosis.

Source-IANS

Generic Drugs for Attention Deficit Hyperactivity Disorder Faces Safety Concerns
The Food and Drug Administration has reported the side effects of using the two generic versions of Concerta, commonly prescribed to treat ADHD.